March 3, 2026 · Form 4 insider transaction
Okey Stephanie sold 3,000 shares of Crinetics Pharmaceuticals, Inc. at $39.67 per share, a transaction worth $119.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.; The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $39.67 per share.